Cargando…
The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada
SIMPLE SUMMARY: The Screen Project was initiated in 2017 to offer BRCA1 and BRCA2 genetic screening to all Canadians over the age of 18 who wish to know their mutation status. Study subjects registered online and were sent a saliva sample kit. Of the 1269 tested individuals between March 2017 and Ja...
Autores principales: | Narod, Steven A., Gojska, Nicole, Sun, Ping, Tryon, Angelina, Kotsopoulos, Joanne, Metcalfe, Kelly, Akbari, Mohammad R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071125/ https://www.ncbi.nlm.nih.gov/pubmed/33920818 http://dx.doi.org/10.3390/cancers13081894 |
Ejemplares similares
-
Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’
por: Kotsopoulos, Joanne, et al.
Publicado: (2014) -
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016) -
Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Zaman, Tasnim, et al.
Publicado: (2019) -
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
por: Chehade, Rania, et al.
Publicado: (2016) -
Salpingectomy and the Risk of Ovarian Cancer in Ontario
por: Giannakeas, Vasily, et al.
Publicado: (2023)